Tivity Health Inc (TVTY) Stake Increased by Dimensional Fund Advisors LP

Share on StockTwits

Dimensional Fund Advisors LP lifted its position in shares of Tivity Health Inc (NASDAQ:TVTY) by 1.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,655,265 shares of the company’s stock after acquiring an additional 29,384 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Tivity Health were worth $41,067,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in TVTY. Advisor Group Inc. increased its holdings in shares of Tivity Health by 364.2% during the 4th quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock worth $29,000 after buying an additional 896 shares during the last quarter. Enlightenment Research LLC acquired a new stake in Tivity Health in the 4th quarter valued at approximately $37,000. First Quadrant L P CA acquired a new stake in Tivity Health in the 4th quarter valued at approximately $65,000. Fort L.P. acquired a new stake in Tivity Health in the 4th quarter valued at approximately $126,000. Finally, Acadian Asset Management LLC acquired a new stake in Tivity Health in the 4th quarter valued at approximately $154,000.

Tivity Health stock opened at $18.87 on Monday. The company has a debt-to-equity ratio of 2.13, a current ratio of 0.86 and a quick ratio of 0.71. Tivity Health Inc has a fifty-two week low of $16.25 and a fifty-two week high of $41.46. The company has a market capitalization of $900.14 million, a P/E ratio of 8.06, a P/E/G ratio of 0.78 and a beta of 1.10.

Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.01. Tivity Health had a net margin of 12.18% and a return on equity of 26.02%. The company had revenue of $214.10 million during the quarter, compared to analysts’ expectations of $200.39 million. During the same quarter last year, the company posted $0.49 EPS. The firm’s revenue was up 42.8% compared to the same quarter last year. On average, sell-side analysts expect that Tivity Health Inc will post 2.35 EPS for the current year.

In other Tivity Health news, Director Bradley S. Karro purchased 2,900 shares of the firm’s stock in a transaction on Friday, March 22nd. The stock was bought at an average price of $16.54 per share, with a total value of $47,966.00. Following the transaction, the director now directly owns 24,696 shares of the company’s stock, valued at approximately $408,471.84. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sara Finley purchased 2,000 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was acquired at an average cost of $17.25 per share, with a total value of $34,500.00. The disclosure for this purchase can be found here. Company insiders own 1.64% of the company’s stock.

Several analysts recently weighed in on TVTY shares. BidaskClub upgraded shares of Tivity Health from a “strong sell” rating to a “sell” rating in a report on Monday, April 1st. Cantor Fitzgerald reiterated a “buy” rating on shares of Tivity Health in a report on Monday, April 22nd. Barrington Research reiterated an “outperform” rating and issued a $40.00 target price on shares of Tivity Health in a report on Wednesday, February 20th. They noted that the move was a valuation call. Chardan Capital reiterated a “buy” rating and issued a $31.00 target price (down previously from $41.00) on shares of Tivity Health in a report on Friday, February 1st. Finally, Jefferies Financial Group dropped their target price on shares of Tivity Health to $29.00 and set a “buy” rating for the company in a report on Wednesday, February 20th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $33.00.

TRADEMARK VIOLATION WARNING: “Tivity Health Inc (TVTY) Stake Increased by Dimensional Fund Advisors LP” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4353856/tivity-health-inc-tvty-stake-increased-by-dimensional-fund-advisors-lp.html.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

See Also: What is the balance sheet?

Want to see what other hedge funds are holding TVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tivity Health Inc (NASDAQ:TVTY).

Institutional Ownership by Quarter for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Berenberg Bank Analysts Give Carl Zeiss Meditec  a €93.00 Price Target
Berenberg Bank Analysts Give Carl Zeiss Meditec a €93.00 Price Target
Carl Zeiss Meditec  PT Set at €88.00 by Independent Research
Carl Zeiss Meditec PT Set at €88.00 by Independent Research
Bayerische Motoren Werke  PT Set at €94.00 by Barclays
Bayerische Motoren Werke PT Set at €94.00 by Barclays
Royal Bank of Canada Analysts Give Bayerische Motoren Werke  a €76.00 Price Target
Royal Bank of Canada Analysts Give Bayerische Motoren Werke a €76.00 Price Target
Continental  Given a €136.00 Price Target by Royal Bank of Canada Analysts
Continental Given a €136.00 Price Target by Royal Bank of Canada Analysts
Hauck & Aufhaeuser Analysts Give Continental  a €130.00 Price Target
Hauck & Aufhaeuser Analysts Give Continental a €130.00 Price Target


© 2006-2019 Ticker Report